Hopf, Linus V. M. http://orcid.org/0000-0002-4372-694X
Baek, Kheewoong http://orcid.org/0000-0002-6853-4936
Klügel, Maren
von Gronau, Susanne
Xiong, Yue
Schulman, Brenda A. http://orcid.org/0000-0002-3083-1126
Article History
Received: 8 December 2021
Accepted: 28 June 2022
First Online: 18 August 2022
Competing interests
: B.A.S. is a member of the scientific advisory boards of Interline Therapeutics and BioTheryx, and is a coinventor of intellectual property related to DCN1 inhibitors licensed to Cinsano. Y.X. is Chief Scientific Officer of Cullgen. The remaining authors declare no competing interests.